CRP and infectious disease: Some evidence suggests that a variety of markers are indicative of the outcome of SFTS patients, such as the C-reactive protein (CRP)–to–albumin ratio (CAR),7 the platelet-to-albumin ratio (PAR),8 and the aggregate index of systemic inflammation (AISI), which represents immunological and inflammatory status as well as the associated infectious disease risk and mortality.9